Real-Time PCR-Based Screening for Homozygous SMN2 Deletion Using Residual Dried Blood Spots
Genes · 2023
DOI: 10.3390/genes14122159 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2023. Verfasst von Yoshihiro Bouike und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Nutrition, Kobe Gakuin University, 518 Arise, Ikawadani-cho, Nishi-ku, Kobe 651-2180, Japan. Hauptthemen laut MEDLINE: Muscular Atrophy, Spinal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Ministry of Education, Culture, Sports, Science, and Technology, Japan, Ministry of Education, Culture, Sports, Science, and Technology, Japan.
Abstract (Originalsprache)
The survival motor neuron 2 (SMN2) gene is a recognized modifier gene of spinal muscular atrophy (SMA). However, our knowledge about the role of SMN2—other than its modification of SMA phenotypes—is very limited. Discussions regarding the relationship between homozygous SMN2 deletion and motor neuron diseases, including amyotrophic lateral sclerosis, have been mainly based on retrospective epidemiological studies of the diseases, and the precise relationship remains inconclusive. In the present study, we first estimated that the frequency of homozygous SMN2 deletion was ~1 in 20 in Japan. We then established a real-time polymerase chain reaction (PCR)-based screening method using residual dried blood spots to identify infants with homozygous SMN2 deletion. This method can be applied to a future prospective cohort study to clarify the relationship between homozygous SMN2 deletion and motor neuron diseases. In our real-time PCR experiment, both PCR (low annealing temperatures) and blood (high hematocrit values and low white blood cell counts) conditions were associated with incorrect results (i.e., false negatives and positives). Together, our findings not only help to elucidate the role of SMN2, but also aid in our understanding of the pitfalls of current SMA newborn screening programs for detecting homozygous SMN1 deletions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Nutrition, Kobe Gakuin University, 518 Arise, Ikawadani-cho, Nishi-ku, Kobe 651-2180, Japan.
- Division of Physiology, Shinko Hospital, 1-4-47 Wakinohama-cho, Chuo-ku, Kobe 651-0072, Japan.
- Department of Clinical Laboratory, Kobe University Hospital, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan.
- Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan.
- Organization for Research Initiative and Promotion, Research Initiative Center, Tottori University, 86 Nishi-cho, Yonago 683-8503, Japan.
- Department of Occupational Therapy, Faculty of Rehabilitation, Kobe Gakuin University, 518 Arise, Ikawadani-cho, Nishi-ku, Kobe 651-2180, Japan.
ORCID-Profile: Hiroyuki Awano, Hisahide Nishio
Förderung
- the Ministry of Education, Culture, Sports, Science, and Technology, Japan
- Ministry of Education, Culture, Sports, Science, and Technology, Japan
Zitieren
APA
Bouike, Y., Sakima, M., Taninishi, Y., Matsutani, T., Noguchi, Y., Bo, R., Awano, H., & Nishio, H. (2023). Real-Time PCR-Based Screening for Homozygous SMN2 Deletion Using Residual Dried Blood Spots. Genes. https://doi.org/10.3390/genes14122159
Vancouver
Bouike Y, Sakima M, Taninishi Y, Matsutani T, Noguchi Y, Bo R, et al. Real-Time PCR-Based Screening for Homozygous SMN2 Deletion Using Residual Dried Blood Spots. Genes. 2023. doi:10.3390/genes14122159
BibTeX
@article{Bouike2023,
author = {Bouike, Yoshihiro and Sakima, Makoto and Taninishi, Yuya and Matsutani, Takanori and Noguchi, Yoriko and Bo, Ryosuke and Awano, Hiroyuki and Nishio, Hisahide},
title = {Real-Time PCR-Based Screening for Homozygous SMN2 Deletion Using Residual Dried Blood Spots},
journal = {Genes},
year = {2023},
doi = {10.3390/genes14122159}
}
EUVIMED